A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...
Based in Rahway, Merck (MRK) is in the Medical sector, and so far this year, shares have seen a price change of -11.86%. The pharmaceutical company is paying out a dividend of $0.81 per share at ...
Merck's Q4 2024 results surpassed expectations, driven by strong oncology sales and growth in Keytruda. See why I think MRK may work for income investors.
In both trials, DOR/ISL met the primary efficacy success criterion for non-inferiority to comparator antiretroviral therapies and primary safety objective RAHWAY, N.J., March 12, 2025--Merck ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.